Brandywine Oak Private Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,828
Closed -$380K 312
2022
Q2
$380K Buy
6,828
+268
+4% +$14.9K 0.05% 205
2022
Q1
$363K Sell
6,560
-628
-9% -$32.2K 0.04% 230
2021
Q4
$402K Sell
7,188
-1,054
-13% -$57.1K 0.04% 218
2021
Q3
$387K Sell
8,242
-466
-5% -$22.5K 0.04% 216
2021
Q2
$364K Sell
8,708
-924
-10% -$35.8K 0.04% 224
2021
Q1
$324K Sell
9,632
-296
-3% -$10.5K 0.05% 189
2020
Q4
$346K Sell
9,928
-1,764
-15% -$61K 0.05% 176
2020
Q3
$405K Sell
11,692
-284
-2% -$9.47K 0.07% 159
2020
Q2
$392K Buy
11,976
+2,492
+26% +$79.5K 0.07% 157
2020
Q1
$285K Sell
9,484
-990
-9% -$29.5K 0.06% 165
2019
Q4
$303K Sell
10,474
-274
-3% -$7.59K 0.06% 180
2019
Q3
$277K Buy
10,748
+276
+3% +$6.98K 0.05% 177
2019
Q2
$267K Sell
10,472
-146
-1% -$3.61K 0.05% 181
2019
Q1
$277K Sell
10,618
-1,288
-11% -$31.7K 0.06% 174
2018
Q4
$274K Buy
+11,906
New +$265K 0.06% 157

Other funds holding NVO

Brandywine Oak Private Wealth's NVO Position: Q3 2022 in Review

Brandywine Oak Private Wealth sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 6,828 shares — an estimated $380K sold.

Brandywine Oak Private Wealth first reported a position in NVO in Q4 2018 and held it in 15 quarters. The position peaked at $405K in Q3 2020. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • Brandywine Oak Private Wealth reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 6,828 Novo Nordisk shares in Q3 2022, an estimated $380K.
  • Brandywine Oak Private Wealth first reported a position in Novo Nordisk in Q4 2018 and held it in 15 quarters.
  • Brandywine Oak Private Wealth's Novo Nordisk position peaked at $405K in Q3 2020.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Brandywine Oak Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.